Les Meilleures Cliniques et Coûts des traitements d'azoospermie en Chine 2026

Primary azoospermia treatments in China include microdissection testicular sperm extraction (Micro-TESE) for non-obstructive cases and vasectomy reversal for obstructive conditions. Specialized Class A Level III clinics like Yanda International Hospital incorporate Joint Commission International (JCI) standards. These centers combine advanced surgical retrieval with traditional Chinese medicine to optimize sperm quality.

• Surgical retrieval: Micro-TESE uses high-power magnification to locate viable sperm in the testes.
• Assisted reproduction: Intracytoplasmic sperm injection (ICSI) follows retrieval to ensure direct egg fertilization.
• Hormonal therapy: Medications like gonadotropins stimulate production in patients with specific endocrine imbalances.
• Integrative approach: Traditional formulas like Wuzi Yanzong Pills are used to improve testicular microcirculation.
• Reconstructive surgery: Vasovasostomy or vasoepididymostomy repairs physical blockages to restore natural sperm flow.

Bookimed Expert Insight: China's top-tier facilities offer a high volume of procedures, with Yanda International Hospital alone serving 2,500,000 patients annually. Leading specialists like Dr. Wang He Tian integrate Western urology with traditional methods to improve the testicular environment. This dual-pathway approach is often more comprehensive than protocols found in strictly Western fertility centers.

Patient Consensus: Patients emphasize the importance of choosing state-affiliated hospitals for proven micro-TESE results. They note that while specialized clinics offer the best value, hiring a translator is essential for navigating the complex medical system.

Clinical success for azoospermia treatment in China depends on the specific diagnosis. Obstructive azoospermia (OA) shows a 100% sperm retrieval rate using aspiration techniques. Non-obstructive cases (NOA) achieve approximately 44.6% retrieval via micro-TESE. Clinical pregnancy rates for these patients typically range from 45.5% to 67.6%.

• Obstructive retrieval: Success reaches nearly 100% with Testicular Sperm Aspiration (TESA).
• Non-obstructive retrieval: Microdissection Testicular Sperm Extraction (micro-TESE) averages 44.6% success.
• Pregnancy rates: Success per ICSI cycle varies between 51.7% and 67.6%.
• Live birth: Cumulative live birth rates reach 46.8% for successful retrievals.

Bookimed Expert Insight: China offers a unique advantage by combining JCI-accredited surgical protocols with traditional medicine. Specialists like Dr. Wang He Tian at Yanda International Hospital integrate these approaches. Data suggests this combination can lead to an effective response rate of 92.1% in some cases. Patients benefit from this dual-track system at Class A level III facilities in Beijing.

Patient Consensus: Patients emphasize the need to confirm whether their condition is obstructive or non-obstructive before traveling. Many recommend choosing surgeons who perform over 100 procedures annually to ensure the highest reliability.

Recognition for male infertility and azoospermia care in China centers on facilities with dedicated andrology units and reproductive research labs. Top institutions like Renji Hospital and Peking University Third Hospital specialize in micro-TESE procedures and genetic diagnosis. These centers often hold JCI accreditation or Class A Level III status.

• Renji Hospital: Hosts the Shanghai Human Sperm Bank and leads genetic research on azoospermia causes.
• Peking University Third: Performs high volumes of micro-TESE surgeries for genetic conditions like Klinefelter syndrome.
• Yanda International Hospital: JCI-accredited facility in Beijing offering integrative traditional and Western andrology treatment protocols.
• Sun Yat-sen University: Specializes in complex microsurgical vasectomy reversals and vasoepididymostomy for obstructive cases.

Bookimed Expert Insight: Yanda International Hospital stands out because it combines major hospital capacity with specialized integrative care. While it serves 2,500,000 patients yearly, its andrology department focuses on chronic and intractable diseases. Dr. Wang He Tian brings expertise in both traditional and modern urology. This dual approach is common in top-tier Class A Level III Chinese clinics but rare elsewhere. Patients often find better support for complex, circulatory-related infertility issues here.

Patient Consensus: Patients note that Beijing and Shanghai are the primary fertility hubs. They often highlight lower costs compared to Western countries but advise verifying credentials through the Chinese Medical Doctor Association. Many emphasize the need to confirm international patient support and follow-up protocols before traveling.

Traditional Chinese Medicine (TCM) does not definitively cure azoospermia. It is an adjuvant therapy alongside Western protocols. Clinical evidence suggest herbs like Wuzi Yanzong Pill may improve sperm quality in non-obstructive cases. Some studies report sperm reappearance in approximately 67% of non-obstructive patients.

• Treatment type: TCM manages non-obstructive azoospermia (NOA) via acupuncture and herbal formulas.
• Physical blockages: TCM generally cannot resolve physical obstructions causing sperm absence.
• Acupuncture benefits: It may regulate testicular blood flow and lower scrotal temperatures.
• Integrative care: Leading centers like Yanda International Hospital combine TCM with international protocols.

Bookimed Expert Insight: Patients should prioritize JCI-accredited facilities even when seeking traditional treatments. Yanda International Hospital in Beijing is a Class A Level III clinic. It manages over 2,500,000 patients annually and employs experts like Dr. Wang He Tian. He leads the TCM department and has authored 10+ clinical books. This level of institutional oversight ensures traditional methods meet modern safety standards.

Patient Consensus: Many patients find that long-term herbal use provides little diagnostic improvement. They recommend testing liver and kidney function regularly during treatment and switching to surgical sperm retrieval if results do not appear within 3 months.

Traditional Chinese Medicine (TCM) practitioners in China primarily prescribe the Wuzi Yanzong Pill to support spermatogenesis. This formula includes five essential seeds such as Goji Berry and Dodder Seed. It aims to tonify kidneys and enhance essence. Doctors often combine these with modern protocols in JCI-accredited facilities.

• Wuzi Yanzong Pill: Contains five seeds to improve sperm count and motility.
• Shengjing Decoction: Clinical hospitals use this to increase sperm concentration and vitality.
• Qilin Pill: Formulated to enhance antioxidant capacity and modulate endocrine function effectively.
• Sovereign herbs: Epimedium and Panax Ginseng are used to mimic testosterone effects.

Bookimed Expert Insight: Top Chinese institutions like Yanda International Hospital integrate TCM with Western methods. Dr. Wang He Tian, a leading expert, focuses on combining andrology with academic herbal inheritance. Data suggests that patients benefit most from these hybrid approaches in Class A Level III clinics. This combination ensures high-level diagnostic precision alongside traditional herbal support for male infertility.

Patient Consensus: Patients note it is important to track progress with monthly semen analysis during herbal treatment. Many suggest using TCM as an adjunct to procedures like microTESE rather than a standalone fix.

Chinese centers manage obstructive azoospermia using microsurgical reconstruction as the primary fertility treatment. Surgeons utilize microsurgical vasoepididymostomy and vasovasostomy to bypass blockages caused by infections or injuries. Specialized facilities often integrate advanced microsurgery with traditional medical protocols to improve post-operative outcomes and sperm motility.

• Microsurgical vasoepididymostomy: Surgeons use longitudinal intussusception techniques to restore patency in cases of epididymal blockage.
• Vasovasostomy procedures: This technique addresses vasal obstructions, frequently resulting from prior surgeries like hernia repairs.
• Endoscopic intervention: Doctors perform transurethral incision of the ejaculatory duct for blockages in the pelvic area.
• Sperm retrieval: Testicular sperm extraction is used when surgical reconstruction is not an viable option.

Bookimed Expert Insight: Class A level III facilities like Yanda International Hospital offer an integrated clinical model. They combine Joint Commission International standards with traditional approaches managed by experts like Dr. Wang He Tian. This dual strategy is helpful because traditional methods are specifically applied to support recovery after complex microsurgical reconstructions.

Patient Consensus: Patients value the high volume of cases handled by Chinese microsurgeons but note that some centers may prioritize sperm extraction for faster IVF results. Many travelers emphasize confirming obstruction via hormone testing before arrival to ensure the correct surgical path.

Micro-TESE is a precise microsurgical procedure used to retrieve sperm from the testicles. Surgeons use 40x magnification to find healthy sperm-producing tubules. It is indicated for non-obstructive azoospermia or when standard sperm retrieval methods have failed to yield results.

• Success rates: Sperm is successfully retrieved in 40% to 60% of cases.
• Tissue preservation: Surgeons remove 70 times less tissue than during conventional biopsy methods.
• Main indications: Recommended for non-obstructive azoospermia and patients with Klinefelter syndrome.
• Prior failure: Used after unsuccessful needle aspiration or standard testicular sperm extraction.

Bookimed Expert Insight: Yanda International Hospital in Beijing represents a unique healthcare model. It holds Joint Commission International accreditation and Class A level III status. Specialists like Dr. Wang He Tian integrate Western reproductive protocols with traditional Chinese medicine. This combined approach is rare and targets urological and andrological diseases for over 2,500,000 patients annually.

Patient Consensus: Patients emphasize pushing for micro-TESE over conventional methods despite a 50/50 success rate. Many note that high hormone levels do not always mean sperm retrieval will fail.